-DoseMe, a leading provider of model-informed precision dosing (MIPD) software, is pleased to announce the continued growth in Au...
-OM1, the leading AI and insights-driven technology and data company specializing in personalized medicine, evidence generation, and real-world evidence, t...
Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic o...
GE HealthCare (Nasdaq: GEHC) announces a groundbreaking advancement in cardiac care with the launch of Caption AI artificial intelligence (AI)-driven softw...
Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ –...
“Research has shown that exosomes carry important information about human health, but studying them has proven challenging,” remarked Paul R. B...
Telix Pharmaceuticals Limited (ASX: TLX) has announced a strategic agreement to partner with ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaf...
Biotechnology Innovation Organization (BIO), a leading lobbying group in Washington, D.C., announced its decision to sever ties with WuXi AppTec, a Chinese...
The newly granted patent enriches Salipro Biotech's comprehensive intellectual property (IP) portfolio, securing its method for stabilizing challenging dru...
The new registry will prospectively collect detailed patient-level data enabling assessment of the natural history of the disease and treatment patterns, a...
The Change Healthcare Ransomware Payment Change Healthcare, a key player in the medical services sector owned by UnitedHealth Group, fell victim t...
ICIG acquires production facilities at five locations in Germany and U.S. Purchase price in low triple-digit million euro range Closing expected for mi...
-Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced it has renewe...
“GenAI is poised to revolutionize how insights leaders harness the collective power of all their research investments to make quick, informed decisio...
© 2024 Biopharma Boardroom. All Rights Reserved.